In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines.

作者: Henry H.L. Chan , Leihong Xiang , Joseph C.K. Leung , Kenneth W.T. Tsang , Kar-neng Lai

DOI: 10.1002/LSM.10118

关键词: CellGene expressionLentigo malignaMelanomaDNA damageCancer researchBiologyFlow cytometryCell cultureMutationPathology

摘要: Background and Objectives Q-switched lasers had been used in the treatment of lentigo maligna but their role remains controversial. While previous studies have addressed change adhesion molecule expression after sub-lethal laser damage, no study has impact damage at a molecular level. The p16 gene proposed as candidate for melanoma. Our objective is to examine effect on melanoma cell lines. Study Design/Materials Methods Three human lines—HTB 66, Sk-mel-24 (HTB 71), G361—were irradiated by Q-switched 755 nm Alexandrite fluencies that ranged from 0.85 2.0 J/cm2. HTB 66 was only line with significant p16INK4a while other two cells lines were negative served control. Protein mRNA assessed flow cytometry RT-PCR, respectively. Results The level protein increased significantly irradiation compared non-irradiated cells. did not p16INK4a-negative (Sk-mel-24 G361). However, there slight increase percentage G0/G1 phase cells. Conclusions Sub-lethal could DNA leading an expression, such would be particularly undesirable patients mutation. Further are warranted inducing Lasers Surg. Med. 32:88–93, 2003. © 2003 Wiley-Liss, Inc.

参考文章(20)
Joseph R. Testa, Nicholas K. Conrad, Nicholas K. Conrad, Bruce E. Johnson, Kazuhiko Nakagawa, Kazuhiko Nakagawa, Michael J. Kelley, Michael J. Kelley, Akihito Kubo, Frederic J. Kaye, Wen Ching Lee, Jin Quan Cheng, Ravi K. Varma, The p16 Status of Tumor Cell Lines Identifies Small Molecule Inhibitors Specific for Cyclin-dependent Kinase 4 Clinical Cancer Research. ,vol. 5, pp. 4279- 4286 ,(1999)
Robert L. van Leeuwen, Sybren K. Dekker, H. Randolph Byers, Bert Jan Vermeer, Joop M. Grevelink, Modulation of α4β1 and α5β1 integrin expression: Heterogeneous effects of Q‐switched Ruby, Nd:YAG, and Alexandrite lasers on melanoma cells in vitro Lasers in Surgery and Medicine. ,vol. 18, pp. 63- 71 ,(1996) , 10.1002/(SICI)1096-9101(1996)18:1<63::AID-LSM8>3.0.CO;2-P
Michael Piepkorn, Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors. Journal of The American Academy of Dermatology. ,vol. 42, pp. 705- 726 ,(2000) , 10.1067/MJD.2000.104687
Ning Wen Zhu, Claire M. Perks, Andrew R. Burd, Jeff M.P. Holly, Changes in the levels of integrin and focal adhesion kinase (FAK) in human melanoma cells following 532 nm laser treatment International Journal of Cancer. ,vol. 82, pp. 353- 358 ,(1999) , 10.1002/(SICI)1097-0215(19990730)82:3<353::AID-IJC8>3.0.CO;2-4
Thomas Soucek, Oliver Pusch, Elke Hengstschläger-Ottnad, Edgar Wawra, Gerhard Bernaschek, Markus Hengstschläger, Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle FEBS Letters. ,vol. 373, pp. 164- 169 ,(1995) , 10.1016/0014-5793(95)01033-B
Bouvier-Labit, Civatte, Bartoli, Renaud, Pellissier, Figarella-Branger, p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index Neuropathology and Applied Neurobiology. ,vol. 25, pp. 408- 416 ,(1999) , 10.1046/J.1365-2990.1999.00203.X
Steven S. Orten, Milton Waner, Scott M. Dinehart, Ricardo H. Bardales, Stephen T. Flock, Q-switched neodymium:yttrium-aluminum-garnet laser treatment of lentigo maligna☆☆☆ Otolaryngology-Head and Neck Surgery. ,vol. 120, pp. 296- 302 ,(1999) , 10.1016/S0194-5998(99)70265-2
Jose Monzon, Ling Liu, Herbert Brill, Alisa M. Goldstein, Margaret A. Tucker, Lynn From, John McLaughlin, David Hogg, Norman J. Lassam, CDKN2AMutations in Multiple Primary Melanomas New England Journal of Medicine. ,vol. 338, pp. 879- 887 ,(1998) , 10.1056/NEJM199803263381305
Mark Chien, Mary Astumian, David Liebowitz, Carrie Rinker-Schaeffer, Walter M. Stadler, In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Cancer Chemotherapy and Pharmacology. ,vol. 44, pp. 81- 87 ,(1999) , 10.1007/S002800050948